therapy-development Videos
7 videos found
Rethink Cell Therapy with Lipid Nanoparticles. Available April 16, 2021 The GenVoy-ILM T Cell Kit for mRNA is an LNP reagent mix optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr® Spark™ instrument and cartridges. It can be used at various stages of cell therapy research and ...
Oct. 5, 2021
Despite being faced with potential demise during the company’s infancy, BioMarin persevered to become one of the world leaders in developing therapies for rare genetic diseases. Watch the 20 year journey of the people of BioMarin finding tomorrows by staying focused on the science to make a big difference for small patient ...
Mar. 10, 2021
ByBioMarin
We are working to enable people with spinal cord injury (SCI) to enjoy life in every way that matters to them using ARC Therapy's targeted, programmed stimulation of the spinal cord. The science behind our investigational ARC Therapy has been developed with rigor and patience, reinforced by multiple peer-reviewed publications in the world’s most ...
Jul. 16, 2022
ByONWARD
Enzymes can be challenging to express and scale up to become biologic therapies. In order to develop their optimized tissue plasmigen activator (tPA) to treat patients with hemorrhagic stroke, Op2Lysis came to Catalent Biologics to develop a cell line expressing their optimized tPA enzyme. By leveraging GPEx® cell line ...
Jan. 31, 2023
The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies. Cala Health’s lead product, Cala Trio™ is the only non-invasive prescription therapy for ...
Oct. 8, 2021
Indivumed is an integrated oncology company, aiming to develop individualized cancer therapies. We provide products and services to obtain an in-depth understanding of the underlying mechanisms of a patient's cancer. ...
Apr. 8, 2021
DiscGenics, Inc. is a privately held, clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. ...
Sep. 1, 2021